Department of Anesthesiology and Critical Care Medicine, 6040A Wood Building, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA.
University of Pennsylvania, Philadelphia, PA, USA.
Crit Care. 2020 Dec 7;24(1):681. doi: 10.1186/s13054-020-03410-7.
Acute respiratory distress syndrome (ARDS) is heterogeneous and may be amenable to sub-phenotyping to improve enrichment for trials. We aimed to identify subtypes of pediatric ARDS based on whole blood transcriptomics.
This was a prospective observational study of children with ARDS at the Children's Hospital of Philadelphia (CHOP) between January 2018 and June 2019. We collected blood within 24 h of ARDS onset, generated expression profiles, and performed k-means clustering to identify sub-phenotypes. We tested the association between sub-phenotypes and PICU mortality and ventilator-free days at 28 days using multivariable logistic and competing risk regression, respectively.
We enrolled 106 subjects, of whom 96 had usable samples. We identified three sub-phenotypes, dubbed CHOP ARDS Transcriptomic Subtypes (CATS) 1, 2, and 3. CATS-1 subjects (n = 31) demonstrated persistent hypoxemia, had ten subjects (32%) with immunocompromising conditions, and 32% mortality. CATS-2 subjects (n = 29) had more immunocompromising diagnoses (48%), rapidly resolving hypoxemia, and 24% mortality. CATS-3 subjects (n = 36) had the fewest comorbidities and also had rapidly resolving hypoxemia and 8% mortality. The CATS-3 subtype was associated with lower mortality (OR 0.18, 95% CI 0.04-0.86) and higher probability of extubation (subdistribution HR 2.39, 95% CI 1.32-4.32), relative to CATS-1 after adjustment for confounders.
We identified three sub-phenotypes of pediatric ARDS using whole blood transcriptomics. The sub-phenotypes had divergent clinical characteristics and prognoses. Further studies should validate these findings and investigate mechanisms underlying differences between sub-phenotypes.
急性呼吸窘迫综合征(ARDS)具有异质性,可能适合亚表型分型以提高试验的针对性。我们旨在根据全血转录组学确定儿科 ARDS 的亚型。
这是一项前瞻性观察性研究,纳入 2018 年 1 月至 2019 年 6 月期间费城儿童医院(CHOP)发生 ARDS 的患儿。我们在 ARDS 发病后 24 小时内采集血液,生成表达谱,并进行 k-均值聚类以确定亚表型。我们使用多变量逻辑回归和竞争风险回归分别测试亚表型与 PICu 死亡率和 28 天无呼吸机天数之间的关联。
我们纳入了 106 名患儿,其中 96 名患儿有可用样本。我们确定了三种亚表型,分别命名为 CHOP ARDS 转录组亚型(CATS)1、2 和 3。CATS-1 组(n=31)患儿持续存在低氧血症,10 名患儿(32%)存在免疫抑制情况,死亡率为 32%。CATS-2 组(n=29)患儿有更多的免疫抑制诊断(48%),低氧血症迅速缓解,死亡率为 24%。CATS-3 组(n=36)患儿合并症最少,低氧血症也迅速缓解,死亡率为 8%。CATS-3 亚组与 CATS-1 亚组相比,死亡率较低(OR 0.18,95%CI 0.04-0.86),拔管概率较高(亚分布 HR 2.39,95%CI 1.32-4.32),在调整混杂因素后。
我们使用全血转录组学确定了三种儿科 ARDS 的亚表型。这些亚表型具有不同的临床特征和预后。进一步的研究应该验证这些发现,并研究亚表型之间差异的潜在机制。